The latest report from Reports and Data reveals that in 2022, the global Coronary Artery Bypass Graft (CABG) Procedures Market reached USD 7.2 billion. It is anticipated that this market will experience a 6.1% compound annual growth rate (CAGR) in revenue over the forecasted period.
Coronary artery disease (CAD), a prevalent form of cardiovascular ailment, arises from the accumulation of plaque within the arteries that carry blood to the heart. While CABG procedures are highly effective treatments for CAD, the incidence of CAD is expected to rise. Furthermore, since the risk of developing CAD and other cardiovascular conditions increases with age, the expanding elderly population is anticipated to contribute to market expansion.
In addition, there is a growing demand for less invasive surgical techniques, which is poised to stimulate global revenue growth. Minimally invasive CABG surgeries, as opposed to traditional open-heart surgery, involve fewer incisions, resulting in reduced discomfort, shorter hospital stays, and faster recovery times for patients. Consequently, both patients and healthcare professionals are increasingly favoring these procedures.
Access Free sample PDF Copy of the Report @
Furthermore, advancements in surgical procedures and equipment are driving market revenue growth. For example, the emergence of robotic-assisted CABG procedures is expected to revolutionize the market by enhancing patient outcomes and providing greater precision and control during surgery.
Key players in the Coronary Artery Bypass Graft (CABG) Procedures Market:
- Abbott Laboratories
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- HeartWare International, Inc.
- MAQUET Holding B.V. & Co. KG
- Medtronic plc
- Sorin Group
- St. Jude Medical, Inc.
- Swissray Global Healthcare Holding, Ltd.
- Teleflex Incorporated
Some Key Highlights in the Report:
- In 2022, the predominant source of revenue was derived from the traditional CABG segment, which constituted the majority of the earnings. This segment involves a surgical procedure where a blood vessel from the patient’s leg, arm, or chest is employed to circumvent blockages in one or more coronary arteries. This procedure has gained widespread acceptance due to its effectiveness in treating coronary artery disease, particularly in patients with severe blockages. Moreover, typical CABG surgery is well-established in the medical field, having been practiced for an extended period.
- The hospital segment captured the largest portion of revenue in 2022. This can be primarily attributed to the substantial volume of surgical procedures conducted within hospital settings. Hospitals are the preferred choice for patients in need of surgical treatments due to their extensive array of specialized surgical departments, access to advanced medical technologies, and highly skilled healthcare professionals. Furthermore, the increasing elderly population and the growing prevalence of chronic ailments such as cancer, cardiovascular disease, and neurological disorders have generated significant demand for surgical interventions within hospital environments.
- In 2022, the North American market led in terms of revenue share. The primary drivers of CABG operations in this region were the elevated rates of cardiovascular diseases and the aging population. Additionally, regional technological advancements and the increasing adoption of minimally invasive procedures are expected to propel revenue growth in the market.
- Asia Pacific is anticipated to exhibit the highest revenue compound annual growth rate (CAGR) throughout the projection period due to rising disposable income and an increasing demand for improved healthcare facilities. The escalating incidence of cardiovascular diseases in emerging nations like China and India has fueled the demand for CABG procedures. Other factors contributing to revenue growth in this region include the availability of cost-effective CABG procedures and rapid developments in healthcare infrastructure.
Get in detailed Research Study @ https://www.reportsanddata.com/report-detail/coronary-artery-bypass-graft-procedures-market
For the purpose of this report, Reports and Data has segmented the global Coronary Artery Bypass Graft (CABG) procedures market on the basis of Product Type Outlook, End-use Outlook, and Regional Outlook:
Product Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Traditional CAGB
- Off-pump CAGB
- Minimally Invasive CAGB
End-use Outlook (Revenue, USD Billion; 2022 – 2032)
- Ambulatory Surgical Centers
Download Summary @ https://www.reportsanddata.com/download-summary-form/6349
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- Rest of Europe
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/6349
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Viral Vector Manufacturing Market By Vector Type (Adenovirus, Retrovirus, Lentivirus, Adeno-associated Virus, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Region Forecast to 2032
Human Papillomavirus Associated Disorder Market By Type (Cervical Cancer, Genital Warts, Anal Cancer, Head and Neck Cancer, and Others), By Diagnosis (Pap Test, HPV DNA Test, Biopsy, and Others), By Treatment (Surgery, Chemotherapy, Immunotherapy, and Others), By End-user (Hospitals, Diagnostic Centers, and Others), and By Region Forecast to 2032
Sexually Transmitted Disease Diagnostics Market, By Disease Type), By Type of Testing, By Device Type, By Product Type, By Usability, By End-use, and By Region Forecast to 2032
Mesotherapy Market By Product Type (Injectors, Mesotherapy Solutions, Mesotherapy Kits, and Others), By Application (Pain Management, Skin Rejuvenation, Hair Restoration, Fat Reduction, and Others), and By Region Forecast to 2032
Metabolic Disorder Therapeutics Market By Product Type (Insulin, Oral Antidiabetic Drugs, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Others), By Disorder Type (Type 1 Diabetes, Type 2 Diabetes, Obesity, Thyroid Disorders, and Others), and By Region Forecast to 2032
Digital Diabetes Management Market By Product & Service (Devices and Application), By Type (Wearable Devices and Handheld Devices), By End-use (Home Care Settings and Diabetes Clinics), and By Region Forecast to 2032
Antimicrobial Susceptibility Testing Market By Product Type (Automated Systems, Manual Systems, Consumables), By Test Type (Disk Diffusion, Broth Dilution, E-test), By End-use (Clinical Diagnostics, Pharma & Biotech Companies, Research & Academic Institutes), and By Region Forecast to 2032
Antithrombin Market Analysis By Type (Human Antithrombin, Bovine Antithrombin), By Application (Therapeutics, Research), By Source (Blood-Derived, Recombinant), and By Region Forecast to 2032
Medical Cart Market By Type (Powered, Non-powered), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region Forecast to 2032
Medical Coding Market By Classification System (International Classification of Diseases (ICD) and Healthcare Common Procedure Code System (HCPCS)), By Component (In-house and Outsourced), and By End-user (Hospitals, Diagnostic Centers, and Other End Users) and by Region Forecast By 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-coronary-artery-bypass-graft-procedures-market